Adult B Acute Lymphoblastic Leukemia — Trials

Adult B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: The First Affiliated Hospital of Soochow University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02281279	Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma	withdrawn	Phase 1 / Phase 2	0	Mayo ClinicOTHER	0	Aug 11, 2016	clinicaltrials
NCT01670084	Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia	withdrawn	Phase 2	0	Mayo ClinicOTHER	1	Oct 30, 2015	clinicaltrials